The NCAM-derived P2 peptide facilitates recovery of cognitive and motor function and ameliorates neuropathology following traumatic brain injury
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
The NCAM-derived P2 peptide facilitates recovery of cognitive and motor function and ameliorates neuropathology following traumatic brain injury. / Klementiev, B; Novikova, T; Korshunova, Irina; Berezin, V; Bock, E.
In: European Journal of Neuroscience, Vol. 27, No. 11, 2008, p. 2885-2896.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The NCAM-derived P2 peptide facilitates recovery of cognitive and motor function and ameliorates neuropathology following traumatic brain injury
AU - Klementiev, B
AU - Novikova, T
AU - Korshunova, Irina
AU - Berezin, V
AU - Bock, E
PY - 2008
Y1 - 2008
N2 - The neural cell adhesion molecule (NCAM) plays a crucial role during development and regeneration of the nervous system, mediating neuronal differentiation, survival and plasticity. Moreover, NCAM regulates learning and memory. A peptide termed P2, corresponding to a 12-amino-acid sequence in the second immunoglobulin (Ig)-like module of NCAM, represents the natural cis-binding site for the first NCAM Ig module. The P2 peptide targets NCAM, thereby inducing a number of intracellular signaling events leading to the stimulation of neurite outgrowth and promotion of neuronal survival in vitro. The present study evaluated the effect of the P2 peptide on functional and histological outcomes following traumatic brain injury inflicted by a cortical cryogenic lesion. Lesioned rats were injected subcutaneously with P2 peptide, 5 mg/kg daily for 15 days beginning 2 h after injury. This treatment significantly improved postlesion recovery of motor and cognitive function, reduced neuronal degeneration, protected cells against oxidative stress, and increased reactive astrogliosis and neuronal plasticity in the sublesional area. P2 appeared rapidly in blood and cerebrospinal fluid after subcutaneous administration and remained detectable in blood for up to 5 h. The results suggest that P2 has therapeutic potential for the treatment of traumatic brain injury.
AB - The neural cell adhesion molecule (NCAM) plays a crucial role during development and regeneration of the nervous system, mediating neuronal differentiation, survival and plasticity. Moreover, NCAM regulates learning and memory. A peptide termed P2, corresponding to a 12-amino-acid sequence in the second immunoglobulin (Ig)-like module of NCAM, represents the natural cis-binding site for the first NCAM Ig module. The P2 peptide targets NCAM, thereby inducing a number of intracellular signaling events leading to the stimulation of neurite outgrowth and promotion of neuronal survival in vitro. The present study evaluated the effect of the P2 peptide on functional and histological outcomes following traumatic brain injury inflicted by a cortical cryogenic lesion. Lesioned rats were injected subcutaneously with P2 peptide, 5 mg/kg daily for 15 days beginning 2 h after injury. This treatment significantly improved postlesion recovery of motor and cognitive function, reduced neuronal degeneration, protected cells against oxidative stress, and increased reactive astrogliosis and neuronal plasticity in the sublesional area. P2 appeared rapidly in blood and cerebrospinal fluid after subcutaneous administration and remained detectable in blood for up to 5 h. The results suggest that P2 has therapeutic potential for the treatment of traumatic brain injury.
KW - Animals
KW - Binding Sites
KW - Brain
KW - Brain Injuries
KW - Cell Differentiation
KW - Cell Survival
KW - Cognition Disorders
KW - Disease Models, Animal
KW - Drug Administration Schedule
KW - Gliosis
KW - Male
KW - Movement Disorders
KW - Myelin Proteins
KW - Nerve Degeneration
KW - Neural Cell Adhesion Molecules
KW - Neuronal Plasticity
KW - Neuroprotective Agents
KW - Protein Binding
KW - Rats
KW - Rats, Wistar
KW - Recovery of Function
KW - Treatment Outcome
U2 - 10.1111/j.1460-9568.2008.06245.x
DO - 10.1111/j.1460-9568.2008.06245.x
M3 - Journal article
C2 - 18540884
VL - 27
SP - 2885
EP - 2896
JO - European Journal of Neuroscience
JF - European Journal of Neuroscience
SN - 0953-816X
IS - 11
ER -
ID: 9971922